...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Validation of the Prognostic Kidney Donor Risk Index Scoring System of Deceased Donors for Renal Transplantation in the Netherlands
【24h】

Validation of the Prognostic Kidney Donor Risk Index Scoring System of Deceased Donors for Renal Transplantation in the Netherlands

机译:核对荷兰肾移植肾移植的预后肾脏捐助者风险指数评分制度

获取原文
获取原文并翻译 | 示例

摘要

Background. The prognostic Kidney Donor Risk Index (KDRI)-developed and internally validated in the United States-is a widely used tool to predict transplant outcome of a deceased donor kidney. The KDRI is currently used for longevity matching between donors and recipients in the United States. Methods. We aimed to externally validate the KDRIdonor-only and KDRIfull as proposed by Rao et al (2009). KDRIdonor-only consist of 10 donor factors, and KDRIfull with an additional 4 transplant factors. We used the Dutch Organ Transplantation Registry to include 3201 adult recipients transplanted from 2002 to 2012. Results. The median Dutch KDRI was 1.21 and comparable with the year 2012 in the United States (median of 1.24). The calibrationslope was 0.98 and 0.96 for the KDRIfull and KDRIdonor-only, respectively, indicating that predictions of graft failure were on average similar. The discriminative ability (Harrell C) of the KDRIfull and the KDRIdonor-only at 5 years was 0.63 (95% confidence interval [CI], 0.62-0.64), and 0.62 (95% CI, 0.61-0.63), respectively. We found misspecification of 3 KDRI factors: age (P = 0.002), weight (P = 0.017), and cold ischemia time (P 0.001). Adding the use of inotropic drugs before donation (P = 0.040) and the interaction between circulatory-death donor kidneys and prolonged cold ischemic time ( 24 hours vs 12 hours; P = 0.059) could improve predictive ability. Conclusions. The KDRI performs equal in the Dutch population. Discriminative ability of the KDRI indicates limited clinical use for adequate individualized decisions. An updated KDRImay contribute to a standardized policymeeting the growing demand of donor kidneys in the Eurotransplant region.
机译:背景。预后肾脏捐赠者风险指数(KDRI) - 在美国开发和内部验证 - 是一种广泛使用的工具,以预测死者肾脏的移植结果。 KDRI目前用于美国捐助者和接受者之间的长寿匹配。方法。我们的目标是外部验证Rao等人(2009)所提出的kdridonor-only和Kdrifull。 Kdridonor-仅由10个供体因子和kdrifull组成,具有额外的4个移植因子。我们使用荷兰器官移植登记处,包括从2002年到2012年移植的3201名成人受援者。结果。中位数荷兰kdri是1.21,与2012年相比(1.24的中位数)。对于Kdrifull和Kdridonor的校准率分别为0.98和0.96,表明移植物失效的预测平均相似。 Kdrifull的鉴别能力(Harrell C)和仅在5年的kdrifonor-ocate为0.63(95%置信区间[Ci],0.62-0.64)和0.62(95%CI,0.61-0.63)。我们发现3 kdri因子的误操作:年龄(p = 0.002),重量(p = 0.017)和冷缺血时间(p <0.001)。在捐赠之前添加了使用的官能药物(P = 0.040)和循环死亡供体肾脏之间的相互作用和延长的冷缺血时间(& 24小时与12小时; p = 0.059)可以提高预测能力。结论。 KDRI在荷兰人种群中执行相同。 KDRI的鉴别能力表示有限的临床用途,适用于适当的个性化决定。更新的KDrimay有助于标准化的Policymeeting在EurotRansplant地区的供体肾脏不断增长的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号